Cargando…
“Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238163/ https://www.ncbi.nlm.nih.gov/pubmed/30417754 http://dx.doi.org/10.1177/1556264618804740 |
_version_ | 1783371319175282688 |
---|---|
author | Thabethe, Siyabonga Slack, Catherine Lindegger, Graham Wilkinson, Abigail Wassenaar, Douglas Kerr, Philippa Bekker, Linda-Gail Mngadi, Kathy Newman, Peter A. |
author_facet | Thabethe, Siyabonga Slack, Catherine Lindegger, Graham Wilkinson, Abigail Wassenaar, Douglas Kerr, Philippa Bekker, Linda-Gail Mngadi, Kathy Newman, Peter A. |
author_sort | Thabethe, Siyabonga |
collection | PubMed |
description | Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollment. We explored site staff and Community Advisory Board (CAB) members’ experiences of trust/mistrust among community members and potential participants. We analyzed 10 focus group discussions with site staff and CAB members at two active South African HIV vaccine trial sites. We report on key characteristics perceived to contribute to the trustworthiness of communicators, as well as factors associated with mistrust. Attributes associated with trustworthy communicators included shared racial identity, competence, and independence (not being “captured”). Key foci for mistrust included explanations about site selection, stored samples, vaccination, and Vaccine Induced Sero-Positivity (VISP). Our findings suggest that community members’ trust is not necessarily global, in which trials are trusted or not; rather, it appears fairly nuanced and is impacted by various perceived attributes of communicators and the information they provide. We make recommendations for clinical trial site stakeholders invested in building trust and for future research into trust at these sites. |
format | Online Article Text |
id | pubmed-6238163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-62381632018-12-10 “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa Thabethe, Siyabonga Slack, Catherine Lindegger, Graham Wilkinson, Abigail Wassenaar, Douglas Kerr, Philippa Bekker, Linda-Gail Mngadi, Kathy Newman, Peter A. J Empir Res Hum Res Ethics Research Risks, Benefits and Trust Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollment. We explored site staff and Community Advisory Board (CAB) members’ experiences of trust/mistrust among community members and potential participants. We analyzed 10 focus group discussions with site staff and CAB members at two active South African HIV vaccine trial sites. We report on key characteristics perceived to contribute to the trustworthiness of communicators, as well as factors associated with mistrust. Attributes associated with trustworthy communicators included shared racial identity, competence, and independence (not being “captured”). Key foci for mistrust included explanations about site selection, stored samples, vaccination, and Vaccine Induced Sero-Positivity (VISP). Our findings suggest that community members’ trust is not necessarily global, in which trials are trusted or not; rather, it appears fairly nuanced and is impacted by various perceived attributes of communicators and the information they provide. We make recommendations for clinical trial site stakeholders invested in building trust and for future research into trust at these sites. SAGE Publications 2018-11-12 2018-12 /pmc/articles/PMC6238163/ /pubmed/30417754 http://dx.doi.org/10.1177/1556264618804740 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Risks, Benefits and Trust Thabethe, Siyabonga Slack, Catherine Lindegger, Graham Wilkinson, Abigail Wassenaar, Douglas Kerr, Philippa Bekker, Linda-Gail Mngadi, Kathy Newman, Peter A. “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title | “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title_full | “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title_fullStr | “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title_full_unstemmed | “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title_short | “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa |
title_sort | “why don’t you go into suburbs? why are you targeting us?”: trust and mistrust in hiv vaccine trials in south africa |
topic | Research Risks, Benefits and Trust |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238163/ https://www.ncbi.nlm.nih.gov/pubmed/30417754 http://dx.doi.org/10.1177/1556264618804740 |
work_keys_str_mv | AT thabethesiyabonga whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT slackcatherine whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT lindeggergraham whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT wilkinsonabigail whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT wassenaardouglas whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT kerrphilippa whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT bekkerlindagail whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT mngadikathy whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica AT newmanpetera whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica |